Cargando…
In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus
Influenza A virus, one of the major human respiratory pathogens, is responsible for annual seasonal endemics and unpredictable periodic pandemics. Despite the clinical availability of vaccines and antivirals, the antigenic diversity and drug resistance of this virus makes it a persistent threat to p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290441/ https://www.ncbi.nlm.nih.gov/pubmed/32466302 http://dx.doi.org/10.3390/v12050581 |
_version_ | 1783545676463865856 |
---|---|
author | Jang, Yejin Shin, Jin Soo Lee, Joo-Youn Shin, Heegwon Kim, Sang Jick Kim, Meehyein |
author_facet | Jang, Yejin Shin, Jin Soo Lee, Joo-Youn Shin, Heegwon Kim, Sang Jick Kim, Meehyein |
author_sort | Jang, Yejin |
collection | PubMed |
description | Influenza A virus, one of the major human respiratory pathogens, is responsible for annual seasonal endemics and unpredictable periodic pandemics. Despite the clinical availability of vaccines and antivirals, the antigenic diversity and drug resistance of this virus makes it a persistent threat to public health, underlying the need for the development of novel antivirals. In a cell culture-based high-throughput screen, a β2-adrenergic receptor agonist, nylidrin, was identified as an antiviral compound against influenza A virus. The molecule was effective against multiple isolates of subtype H1N1, but had limited activity against subtype H3N2, depending on the strain. By examining the antiviral activity of its chemical analogues, we found that ifenprodil and clenbuterol also had reliable inhibitory effects against A/H1N1 strains. Field-based pharmacophore modeling with comparisons of active and inactive compounds revealed the importance of positive and negative electrostatic patterns of phenyl aminoethanol derivatives. Time-of-addition experiments and visualization of the intracellular localization of nucleoprotein NP demonstrated that an early step of the virus life cycle was suppressed by nylidrin. Ultimately, we discovered that nylidrin targets hemagglutinin 2 (HA2)-mediated membrane fusion by blocking conformational change of HA at acidic pH. In a mouse model, preincubation of a mouse-adapted influenza A virus (H1N1) with nylidrin completely blocked intranasal viral infection. The present study suggests that nylidrin could provide a core chemical skeleton for the development of a direct-acting inhibitor of influenza A virus entry. |
format | Online Article Text |
id | pubmed-7290441 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72904412020-06-15 In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus Jang, Yejin Shin, Jin Soo Lee, Joo-Youn Shin, Heegwon Kim, Sang Jick Kim, Meehyein Viruses Article Influenza A virus, one of the major human respiratory pathogens, is responsible for annual seasonal endemics and unpredictable periodic pandemics. Despite the clinical availability of vaccines and antivirals, the antigenic diversity and drug resistance of this virus makes it a persistent threat to public health, underlying the need for the development of novel antivirals. In a cell culture-based high-throughput screen, a β2-adrenergic receptor agonist, nylidrin, was identified as an antiviral compound against influenza A virus. The molecule was effective against multiple isolates of subtype H1N1, but had limited activity against subtype H3N2, depending on the strain. By examining the antiviral activity of its chemical analogues, we found that ifenprodil and clenbuterol also had reliable inhibitory effects against A/H1N1 strains. Field-based pharmacophore modeling with comparisons of active and inactive compounds revealed the importance of positive and negative electrostatic patterns of phenyl aminoethanol derivatives. Time-of-addition experiments and visualization of the intracellular localization of nucleoprotein NP demonstrated that an early step of the virus life cycle was suppressed by nylidrin. Ultimately, we discovered that nylidrin targets hemagglutinin 2 (HA2)-mediated membrane fusion by blocking conformational change of HA at acidic pH. In a mouse model, preincubation of a mouse-adapted influenza A virus (H1N1) with nylidrin completely blocked intranasal viral infection. The present study suggests that nylidrin could provide a core chemical skeleton for the development of a direct-acting inhibitor of influenza A virus entry. MDPI 2020-05-25 /pmc/articles/PMC7290441/ /pubmed/32466302 http://dx.doi.org/10.3390/v12050581 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jang, Yejin Shin, Jin Soo Lee, Joo-Youn Shin, Heegwon Kim, Sang Jick Kim, Meehyein In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title | In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title_full | In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title_fullStr | In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title_full_unstemmed | In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title_short | In Vitro and In Vivo Antiviral Activity of Nylidrin by Targeting the Hemagglutinin 2-Mediated Membrane Fusion of Influenza A Virus |
title_sort | in vitro and in vivo antiviral activity of nylidrin by targeting the hemagglutinin 2-mediated membrane fusion of influenza a virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290441/ https://www.ncbi.nlm.nih.gov/pubmed/32466302 http://dx.doi.org/10.3390/v12050581 |
work_keys_str_mv | AT jangyejin invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus AT shinjinsoo invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus AT leejooyoun invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus AT shinheegwon invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus AT kimsangjick invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus AT kimmeehyein invitroandinvivoantiviralactivityofnylidrinbytargetingthehemagglutinin2mediatedmembranefusionofinfluenzaavirus |